Australia’s SRT Market to Remain Grounded

The Australian Prudential Regulation Authority, or APRA, remains a firm outlier in its resistance to the significant risk transfer, or SRT, market. As of March 2026, the local regulator continues to maintain a “super-equivalent” framework, a designation that refers to APRA’s policy of imposing capital and liquidity requirements that exceed international Basel III minimums to ensure domestic resilience.

The framework intentionally prioritizes simplicity over the perceived complexity of synthetic SRT structures. APRA Chair John Lonsdale recently reinforced this stance at the Australian Financial Review Banking Summit, noting that while the national regime aligns broadly with Basel III standards, the regulator remains committed to a framework tailored to local circumstances. Lonsdale specifically articulated that:

“Although Australia is generally Basel III compliant, we believe in a framework tailored to Australia’s unique circumstances and the characteristics of our local industry. That means we are super-equivalent in some areas but we also simplify Basel’s rules where appropriate.”

This regulatory approach is the foundation of Australia’s current securitization framework, which excludes more complex instruments. Lonsdale explicitly noted that lessons from the GFC suggest risks from complex and opaque forms of securitizations, such as SRT, may not be apparent until the onset of significant stress.

Consequently, while the global market for SRTs continues to grow, the outlook for a dedicated domestic Australian market remains challenged by a regulator that views such instruments as potentially unsuitable for the specific structure of the Australian market.

In the absence of a synthetic SRT framework, Australian banks are increasingly turning to capital relief partnerships that avoid synthetic structures entirely. The trend was evidenced in a strategic capital partnership announced by the Bank of Queensland, or BOQ, with Challenger Ltd., an Australian investment manager and annuity provider. Rather than utilizing a synthetic structure, BOQ executed a 3.7 billion Australian dollars whole-of-loan sale of equipment finance assets to Challenger.

Under the agreement, BOQ transferred the direct credit risk of the assets to Challenger while retaining the customer relationship through ongoing servicing. The forward flow agreement, with an initial term of 12 months, also sees Challenger take the credit risk of newly originated assets while BOQ maintains the customer relationships.

While regulated banks – typically referred to as ADIs – navigate this restrictive framework, the nonbank sector has demonstrated that the technical capacity for SRTs already exists within the Australian landscape. Earlier this year, Macquarie Capital completed a rare Australian SRT transaction tied to a reference pool of approximately $1 billion in high-yield corporate loans. Unlike the transactions explored by regulated banks, this deal was not motivated, or constrained, by regulatory capital requirements but functioned as a risk transfer trade to optimize internal balance-sheet capacity.

The structural divide between bank and nonbank risk management highlights the current limits of the Australian market. While Macquarie Capital utilized a synthetic transaction for internal limit management, ADIs remain restricted to cash-based alternatives.

According to analysis from Westpac Strategy, the timeline for any shift in this regulatory stance likely depends on the conclusion of APRA’s broader liquidity review, known as Workstream 2, which is exploring broadening eligibility for high-quality liquid asset pools.

While liquidity settings and capital frameworks are separate prudential concerns, APRA is prioritizing the modernization of eligibility for high-quality liquid asset pools to align Australian banks with international peers. Westpac suggests that this “significant review” acts as a prerequisite: Until APRA finalizes its consultation response in the second half of 2027, the regulator is unlikely to dedicate the necessary bandwidth to recalibrating the capital treatment for more-complex synthetic instruments.